Guest Speakers

Mylin A. Torres, M.D. Co-Leader of Cancer Prevention and Control Program Louisa and Rand Glenn Family Chair in Breast Cancer Research Associate Professor Department of Radiation Oncology Winship Cancer Institute Emory University School of Medicine Specialty: Breast Cancer

Dr. Mylin Torres is a board-certified radiation oncologist who specializes in the treatment of breast cancer. She is currently the Co-Leader of the Cancer Prevention Control Research Program and holds the Louisa and Rand Glenn Family Chair in Breast Cancer Research. Her research program is dedicated to understanding the biology underlying treatment-related side effects, including chronic inflammation, radiation-induced skin changes, and cancer-related fatigue, and to developing interventions which will improve the life quality of breast cancer survivors. She is also examining ways that radiation can be used to help women with metastatic disease.

Dr. Torres has written and co-authored a number of publications and abstracts. She has received highly competitive grants from the National Cancer Institute (NCI), Radiation Therapy Oncology Group (RTOG), Winship Cancer Institute, and Susan G. Komen to support her research on the detection and treatment of breast cancer therapy-induced toxicities. For her outstanding care of patients, Dr. Torres was awarded the Atlanta Business Chronicle’s Healthcare Heroes Rising Star, the Winship Cancer Institute Above and Beyond Award, and The Winship Annual Mentorship Award. Atlanta Magazine also named her as one of the “Women Making a Mark” in the Atlanta community. She is currently on the Editorial Board for the Journal of Clinical Oncology and serves on the Advisory Committee on Breast Cancer in Young Women for the U.S. based Centers for Disease Control and Prevention (CDC).

Dr. Torres graduated magna cum laude from Harvard University with a bachelor’s degree in biology. She then went on to receive her medical degree from Stanford University before completing her training in radiation oncology at The University of Texas MD Anderson Cancer Center. Dr. Torres is currently an Associate Professor in the Department of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine.

JoAnne Zujewski, M.D. JZ Oncology 2019

Dr. Jo Anne Zujewski is an internationally recognized expert in breast cancer therapeutics and clinical trial development. She has a broad base of experience in all aspects of clinical trial design and conduct. Before establishing her own consulting practice in 2016, Dr. Zujewski served as Head, Breast Cancer Therapeutics, in the Clinical Investigation Branch of the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI), USA. Dr. Zujewski also was the senior advisor for breast cancer in the NCI’s Center for Global Health. She has extensive experience in global health, specifically working with health care providers and advocates in low and middle resourced countries to help them strengthening their cancer control programs.

Prof. Wilfred Ngwa

Director of Global Health Catalyst (GHC) at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School

Attachments area

Michael Stead

Prof Riccardo Audusio

Professor of Surgery, Department of Surgery, Sahlgrenska University Hospital, Gothenburg.Sweden
United Kingdom

Dr, Verna Venderpuye
Senior consultant at the National Centre for Radiotherapy and Nuclear Medicine, Korle Bu Teaching Hospital, Ghana.

Dr. Anuja Jhingran

Dr. Anuja Jhingran earned her M.D. at Texas Tech University in 1988, followed by residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology. She began her career as an Assistant Professor at The University of Texas MD Anderson Cancer Center in 1996 and has advanced to a Professor of Radiation Oncology in the Section of Gynecology. She is a physician specializing in the treatment of gynecologic cancers. Clinically, she is interested in the management of advanced ovarian, cervical, and endometrial cancers and the use of advanced radiation techniques to minimize toxicity. In addition, Dr. Jhingran is heavily involved with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG) in the development of patient care studies to treat gynecologic cancers and is the national Principal Investigator of several accruing studies including a phase III study in cervical cancer. Dr. Jhingran travels extensively internationally for cancer education. She is passionate about women’s health issues and especially as it relates to developing country’s efforts to establish improved health care for the general populace, not just the financially able.